Opioid Use Disorder Outcomes In another study by Wang, Volkow, and colleagues, which included roughly 33,000 individuals with Type 2 diabetes and opioid use disorder, semaglutide was associated with a 42-68% lower risk of opioid overdoses compared to other diabetes medications during the 1-year follow-up period (Wang et al., 2024b)
During shortages of FDA-approved products containing semaglutide, such as Ozempic, compounded semaglutide has been available as an alternative option
Additionally, Ozempic slows down gastric emptying, contributing to improved blood sugar control and potentially aiding weight loss in individuals with type 2 diabetes
coli , respectively
It blocks histamine (H1) receptors, which are involved in alertness and arousal
In parallel, smaller studies and case series continue to report on off-label use, adding to our knowledge